Combined Cardiac Arrhythmias Leading to Electrical Chaos Developed in the Convalescent Phase of SARS-CoV-2 Infection: A Case Report and Literature Review.

Combined Cardiac Arrhythmias Leading to Electrical Chaos Developed in the Convalescent Phase of SARS-CoV-2 Infection: A Case Report and Literature Review.

Publication date: Aug 27, 2025

Background: Acute SARS-CoV-2 infection may induce cardiac arrhythmias associated with viral myocarditis, which typically disappear in the convalescent phase after healing of the myocardial inflammation. Methods: We report the case of a 37-year-old woman with a childhood history of atrial septal defect repair and stable normofrequent atrial rhythm, who presented two months post-COVID-19 with palpitations and dizziness. Diagnostic evaluation included cardiac magnetic resonance imaging (CMR), 24 h Holter electrocardiogram (ECG) monitoring, and laboratory assessments over a 3-year period. Results: CMR suggested subacute myocarditis, and Holter ECG revealed multiple discernible complex cardiac arrhythmias including atrial bradycardia, intermittent junctional rhythm (JR), atrial fibrillation (AF), and non-sustained ventricular tachycardia. Laboratory results showed a moderate but transient increase in lactate dehydrogenase, persistently mildly elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP), and immunoglobulin A (IgA), with all other cardiac, inflammatory, immunologic, and organ function parameters remaining normal. In spite of chaotic cardiac rhythm with alternating JR, AF, and atrial normofrequent rhythm with frequent blocked supraventricular beats and increasing atrioventricular conduction time, no therapeutic intervention was necessary during follow-up, and a conservative treatment approach was agreed with the patient. Two years post-COVID-19 infection, the patient returned to a normofrequent atrial rhythm with a markedly prolonged PQ time (500 ms) and a different P wave morphology compared to pre-COVID, without other rhythm disturbances. Conclusions: This case demonstrates a rare pattern of post-viral arrhythmias first emerging in the convalescent phase and resolving spontaneously after two years. It underscores the need for long-term rhythm surveillance following COVID-19, even in patients with prior structural heart disease and a stable baseline rhythm.

Open Access PDF

Concepts Keywords
Laboratory case report
Months complex cardiac arrhythmia
Myocardial long COVID
Organ
Pro

Semantics

Type Source Name
disease MESH Cardiac Arrhythmias
disease MESH SARS-CoV-2 Infection
pathway REACTOME SARS-CoV-2 Infection
pathway KEGG Viral myocarditis
disease MESH inflammation
disease IDO history
disease MESH atrial septal defect
disease MESH myocarditis
disease MESH bradycardia
disease MESH atrial fibrillation
disease MESH ventricular tachycardia
disease IDO intervention
disease MESH infection
disease MESH heart disease
disease MESH long COVID
disease MESH viral infection
disease IDO immune response
disease MESH channelopathies
disease MESH abnormalities
drug DRUGBANK Hexachlorophene
disease MESH fibrosis
disease IDO cell
disease IDO susceptibility
disease MESH tachyarrhythmias
disease MESH ventricular ectopic beats
disease MESH edema
disease MESH allergies
disease MESH autoimmune disease
disease MESH extrasystole
disease MESH atrial flutter
disease IDO blood
drug DRUGBANK Fibrinogen Human
drug DRUGBANK Von Willebrand Factor Human
drug DRUGBANK Urea
drug DRUGBANK Nitrogen
drug DRUGBANK Uric Acid
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Cholesterol
drug DRUGBANK Histamine

Original Article

(Visited 17 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *